Supernus Pharmaceuticals (SUPN) News Today $35.51 +0.41 (+1.17%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$35.52 +0.01 (+0.01%) As of 08/1/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock SUPN Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Supernus Pharmaceuticals (NASDAQ:SUPN) Stock Rating Upgraded by Wall Street Zen2 hours ago | americanbankingnews.comSupernus Pharmaceuticals (SUPN) Reports Earnings Tomorrow: What To Expect3 hours ago | finance.yahoo.comSupernus Pharmaceuticals (NASDAQ:SUPN) Raised to "Buy" at Wall Street ZenAugust 3 at 3:44 AM | marketbeat.comSupernus Pharmaceuticals (NASDAQ:SUPN) Upgraded at Cantor FitzgeraldAugust 1 at 2:16 AM | americanbankingnews.comSupernus Pharmaceuticals Completes Acquisition of Sage TherapeuticsJuly 31, 2025 | tipranks.comSupernus Pharmaceuticals Completes Acquisition of Sage TherapeuticsJuly 31, 2025 | globenewswire.comSupernus Pharmaceuticals (NASDAQ:SUPN) Upgraded by Cantor Fitzgerald to "Overweight" RatingJuly 31, 2025 | marketbeat.com65,585 Shares in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Purchased by Universal Beteiligungs und Servicegesellschaft mbHJuly 31, 2025 | marketbeat.comHead to Head Analysis: Supernus Pharmaceuticals (NASDAQ:SUPN) versus Acura Pharmaceuticals (OTCMKTS:ACUR)July 31, 2025 | americanbankingnews.comSupernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Could Be 50% Below Their Intrinsic Value EstimateJuly 30, 2025 | finance.yahoo.comWhy Supernus Pharmaceuticals (SUPN) Stock Is Up TodayJuly 30, 2025 | msn.comSupernus Pharmaceuticals (SUPN) Projected to Post Quarterly Earnings on TuesdayJuly 30, 2025 | marketbeat.comSupernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Purchased by GSA Capital Partners LLPJuly 29, 2025 | marketbeat.comRoyce & Associates LP Boosts Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)July 29, 2025 | marketbeat.comSupernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Sage Therapeutics, Inc. Tender OfferJuly 28, 2025 | globenewswire.comPacer Advisors Inc. Has $13.22 Million Stock Position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)July 27, 2025 | marketbeat.comBranded Pharmaceuticals Stocks Q1 Recap: Benchmarking Supernus Pharmaceuticals (NASDAQ:SUPN)July 25, 2025 | msn.comBurney Co. Lowers Stock Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)July 24, 2025 | marketbeat.comSupernus Pharmaceuticals Inc (SUPN) Announces Upcoming Q2 2025 Financial Results Release | SUPN ...July 22, 2025 | gurufocus.comSupernus Pharmaceuticals to Announce Second Quarter 2025 Financial Results and Host Conference Call and Webcast on August 5, 2025July 22, 2025 | globenewswire.comVictory Capital Management Inc. Has $22.03 Million Stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)July 22, 2025 | marketbeat.comGW&K Investment Management LLC Buys 176,091 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)July 21, 2025 | marketbeat.comBank of New York Mellon Corp Reduces Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)July 21, 2025 | marketbeat.comSupernus Pharmaceuticals (NASDAQ:SUPN) Cut to "Hold" at Wall Street ZenJuly 20, 2025 | marketbeat.comWhy Supernus Pharmaceuticals (SUPN) Shares Are Falling TodayJuly 18, 2025 | msn.comTributary Capital Management LLC Reduces Stock Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)July 17, 2025 | marketbeat.comPrincipal Financial Group Inc. Boosts Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)July 15, 2025 | marketbeat.comSAGE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sage Therapeutics, Inc. - SAGEJuly 14, 2025 | businesswire.comRice Hall James & Associates LLC Sells 12,456 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)July 14, 2025 | marketbeat.comStephens Investment Management Group LLC Has $56.94 Million Stock Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)July 13, 2025 | marketbeat.comWall Street Zen Upgrades Supernus Pharmaceuticals (NASDAQ:SUPN) to BuyJuly 12, 2025 | marketbeat.com2 Cash-Heavy Stocks to Own for Decades and 1 to Approach with CautionJuly 10, 2025 | finance.yahoo.comBranded Pharmaceuticals Stocks Q1 Recap: Benchmarking Merck (NYSE:MRK)July 9, 2025 | msn.comMeritage Portfolio Management Acquires 10,622 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)July 4, 2025 | marketbeat.comSupernus Pharmaceuticals, Inc. (SUPN) - Yahoo FinanceJuly 3, 2025 | finance.yahoo.com8,151 Shares in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Bought by Robeco Institutional Asset Management B.V.July 3, 2025 | marketbeat.comSupernus Pharmaceuticals’s Q1 Earnings Call: Our Top 5 Analyst QuestionsJune 27, 2025 | msn.comSupernus Pharmaceuticals (NASDAQ:SUPN) shareholders have earned a 6.8% CAGR over the last five yearsJune 23, 2025 | uk.finance.yahoo.comSupernus Pharmaceuticals (NASDAQ:SUPN) Lowered to Hold Rating by Wall Street ZenJune 21, 2025 | marketbeat.comSAGE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sage Therapeutics, Inc. - SAGEJune 18, 2025 | businesswire.comSupernus Pharma to Buy Sage Therapeutics for Up to $795 MillionJune 16, 2025 | marketwatch.comSupernus enters depression drug market with up to $795 million Sage dealJune 16, 2025 | msn.comSupernus to acquire depression drugmaker SageJune 16, 2025 | msn.comSupernus Pharmaceuticals Gets Retail Excited Over $795M Acquisition Plan For Sage TherapeuticsJune 16, 2025 | msn.comALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Sage Therapeutics, Inc.June 16, 2025 | prnewswire.comSupernus Pharmaceuticals (SUPN) to Acquire Sage Therapeutics in $795M DealJune 16, 2025 | gurufocus.comSupernus Pharmaceuticals to Acquire Sage Therapeutics, Strengthening its Neuropsychiatry ...June 16, 2025 | gurufocus.comSupernus Pharmaceuticals to Acquire Sage Therapeutics in a Strategic Move | SUPN stock newsJune 16, 2025 | gurufocus.comSage Therapeutics Stock Soars 35% After Sale to Supernus Pharmaceuticals. What We Know.June 16, 2025 | barrons.comSupernus Pharmaceuticals to Acquire Sage Therapeutics, Strengthening its Neuropsychiatry ...June 16, 2025 | gurufocus.com Get Supernus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SUPN and its competitors with MarketBeat's FREE daily newsletter. Email Address SUPN Media Mentions By Week SUPN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SUPN News Sentiment▼0.840.46▲Average Medical News Sentiment SUPN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SUPN Articles This Week▼146▲SUPN Articles Average Week Get Supernus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SUPN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CORT News JAZZ News PRGO News PCRX News NKTR News OMER News ASMB News CPIX News LLY News JNJ News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SUPN) was last updated on 8/4/2025 by MarketBeat.com Staff From Our PartnersWall Street Laughed. Now They're Buying.For six months, I’ve been pounding the table on a major gold miner—while Twitter pundits laughed. But now, the...Golden Portfolio | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Create New Advertiser | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredOut with the old (A.I.) - In with the new (E.I.)One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredStrange twist to Bitcoin’s rallyThe #1 crypto to buy today Better than Bitcoin? (top crypto for less than $1) Over the past 15 years, B...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Supernus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Supernus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SUPN Stock Alerts